Continuous Glucose Monitoring: Impact on Hypoglycemia.

作者: Cornelis A. J. van Beers , J. Hans DeVries

DOI: 10.1177/1932296816653411

关键词: HypoglycemiaGlucose controlGlycemicDiabetes mellitusContinuous glucose monitoringIntensive care medicineSevere hypoglycemiaMedicine

摘要: The necessity of strict glycemic control is unquestionable. However, hypoglycemia remains a major limiting factor in achieving satisfactory glucose control, and evidence mounting to show that hy...

参考文章(77)
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
LA Gonder-Frederick, DJ Cox, WL Clarke, The Emotional, Social, and Behavioral Implications of Insulin-Induced Hypoglycemia. Seminars in Clinical Neuropsychiatry. ,vol. 2, pp. 57- 65 ,(1997) , 10.1053/SCNP00200057
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, None, Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England Journal of Medicine. ,vol. 359, pp. 1464- 1476 ,(2008) , 10.1056/NEJMOA0805017
Diabetes Control and Complications Trial, None, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. ,vol. 353, pp. 2643- 2653 ,(2005) , 10.1056/NEJMOA052187
Cornelis A.J. van Beers, Susanne J. Kleijer, Erik H. Serné, Petronella H. Geelhoed-Duijvestijn, Frank J. Snoek, Mark H.H. Kramer, Michaela Diamant, Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia BMC Endocrine Disorders. ,vol. 15, pp. 42- 42 ,(2015) , 10.1186/S12902-015-0040-3
J. Hermanides, K. Nørgaard, D. Bruttomesso, C. Mathieu, A. Frid, C. M. Dayan, P. Diem, C. Fermon, I. M. E. Wentholt, J. B. L. Hoekstra, J. H. DeVries, Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabetic Medicine. ,vol. 28, pp. 1158- 1167 ,(2011) , 10.1111/J.1464-5491.2011.03256.X
MD Ritholz, A Atakov‐Castillo, M Beste, EA Beverly, A Leighton, K Weinger, H Wolpert, None, Psychosocial factors associated with use of continuous glucose monitoring Diabetic Medicine. ,vol. 27, pp. 1060- 1065 ,(2010) , 10.1111/J.1464-5491.2010.03061.X
Peter Calhoun, John Lum, Roy W. Beck, Craig Kollman, Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technology & Therapeutics. ,vol. 15, pp. 758- 761 ,(2013) , 10.1089/DIA.2013.0042
O. Kordonouri, E. Pankowska, B. Rami, T. Kapellen, R. Coutant, R. Hartmann, K. Lange, M. Knip, T. Danne, Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment Diabetologia. ,vol. 53, pp. 2487- 2495 ,(2010) , 10.1007/S00125-010-1878-6